China NMPA Product Recall - guiding catheter

Medtronic Inc. initiated a voluntary Class II recall of its guiding catheters on April 15, 2021, as reported by the National Medical Products Administration (NMPA). The recall was prompted by a critical issue involving unsealed sterile packaging bags affecting specific models and batches of the product. This packaging defect raised concerns regarding the sterility and safety of the guiding catheters, which are medical devices used in various interventional procedures. Medtronic (Shanghai) Management Co., Ltd. reported the issue to the NMPA, leading to the public announcement of the recall. The regulatory framework for this action falls under the NMPA's medical device oversight. The required action by the company is the immediate retrieval of the affected guiding catheter units from the market. Detailed information on the specific product models, specifications, and batch numbers subject to the recall can be found in the "Medical Device Recall Event Report Form"附件. This proactive measure aims to mitigate potential risks to patient health and ensure compliance with medical device safety standards.